Moutushi Islam

Moutushi Islam

Auto-generated profile, based on publicly available information

Moutushi Islam

National Institute of Genetics, Research Organization of Information and Systems (ROIS) 1 Department of Chromosome Science Yata 1111, Mishima, Shizuoka 411-8540

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in EMBO Reports
Verified
Journal Article
Open access
YHYuki Hatoyama
Yuki Hatoyama
MIMoutushi Islam
Moutushi Islam
ABAdam G Bond
Adam G Bond
KHKen-Ichiro Hayashi
Ken-Ichiro Hayashi
ACAlessio Ciulli
Alessio Ciulli
MKMasato Kanemaki
Masato Kanemaki
Acute protein knockdown is a powerful approach to dissecting protein function in dynamic cellular processes. We previously reported an improved auxin-inducible degron system, AID2, but recently noted that its ability to induce degradation of some essential replication factors, such as ORC1 and CDC6, was not enough to induce lethality. Here, we present combinational degron technologies to control two proteins or enhance target depletion. For this purpose, we initially compare PROTAC-based degrons, dTAG and BromoTag, with AID2 to reveal their key features and then demonstrate control of cohesin and condensin with AID2 and BromoTag, respectively. We develop a double-degron system with AID2 and BromoTag to enhance target depletion and accelerate depletion kinetics and demonstrate that both ORC1 and CDC6 are pivotal for MCM loading. Finally, we show that co-depletion of ORC1 and CDC6 by the double-degron system completely suppresses DNA replication, and the cells enter mitosis with single-chromatid chromosomes, indicating that DNA replication is uncoupled from cell cycle control. Our combinational degron technologies will expand the application scope for functional analyses.

1 July 2025 in Journal of Cell Science
Verified
Journal Article
Closed access
MIMoutushi Islam
Moutushi Islam
TNTakefumi Negishi
Takefumi Negishi
NKNaomi Kitamoto
Naomi Kitamoto
YHYuki Hatoyama
Yuki Hatoyama
KGKanae Gamo
Kanae Gamo
MKMasato Kanemaki
Masato Kanemaki
Protein knockdown using an improved auxin-inducible degron (AID2) technology has proven to be a powerful tool for studying protein function. The current approach requires the fusion of target proteins with a degron tag, a process typically achieved through CRISPR knock-in. However, knock-in remains challenging in non-model organisms and humans, limiting the broader applicability of AID2. To overcome this limitation, we developed a single-chain antibody AID2 (scAb-AID2) system. This approach employs an adaptor composed of a single-chain antibody fused with a degron, which recognizes a target protein and induces rapid degradation in the presence of the inducer 5-Ph-IAA. We demonstrated that scAb-AID2, in combination with an anti-GFP nanobody, degraded GFP-fused proteins in human cells and Caenorhabditis elegans. Furthermore, we showed that endogenous p53 and H/K-RAS were conditionally degraded in cells expressing an adaptor encoding an anti-p53 nanobody and -RAS monobody, respectively, and led to aphidicolin sensitivity in cell culture and growth inhibition in mouse xenografts. This study paves the way for broader application of AID2-based target depletion in model and non-model organisms and for advancing therapeutic strategies.

24 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MIMoutushi Islam
Moutushi Islam
TNTakefumi Negishi
Takefumi Negishi
NKNaomi Kitamoto
Naomi Kitamoto
YHYuki Hatoyama
Yuki Hatoyama
KGKanae Gamo
Kanae Gamo
MKMasato Kanemaki
Masato Kanemaki
Protein knockdown using an improved auxin-inducible degron (AID2) technology has proven to be a powerful tool for studying protein function. The current approach requires the fusion of target proteins with a degron tag, a process typically achieved through CRISPR knock-in. However, knock-in remains challenging in non-model organisms and humans, limiting the broader applicability of AID2. To overcome this limitation, we developed a single-chain antibody AID2 (scAb-AID2) system. This approach employs an adaptor composed of a single-chain antibody fused with a degron, which recognises a target protein and induces rapid degradation in the presence of the inducer 5-Ph-IAA. We demonstrated that scAb-AID2, in combination with an anti-GFP nanobody, degraded GFP-fused proteins in human cells and C. elegans . Furthermore, we showed that endogenous p53 and H/K-RAS were conditionally degraded in cells expressing an adaptor encoding an anti-p53 nanobody and -RAS monobody, respectively, and led to aphidicolin sensitivity in cell culture and growth inhibition in mouse xenografts. This study paves the way for broader application of AID2-based target depletion in model and non-model organisms and for advancing therapeutic strategies.